- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04815681
Evaluating an Online Wellness Intervention for Greek Adolescents
Evaluating an Online Single-session Intervention for Mental Health and Wellness of Greek Adolescents
The investigators are evaluating the effects of an online single-session mental health intervention (the Common Elements Toolbox; COMET). To evaluate COMET, the investigators are conducting a randomized controlled trial with Greek adolescents attending high school in the Attica region in Greece. Students will be randomized to the COMET condition or to an active control condition.
Primary outcome measures (depressive symptoms, anxiety symptoms, subjective well-being) will be measured at two weeks post-intervention and four weeks post-intervention.
The investigators will evaluate COMET as a universal intervention (using the full sample) and as a targeted intervention (analyzing those who reported elevated depressive symptoms or anxiety symptoms at baseline).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Athens, Greece, 15121
- Eginition Hospital National and Kapodistrian University of Athens School of Medicine
-
-
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- UNIVERSITY of PENNSYLVANIA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Between 13 and 20 years old and a student at a participating Greek high school. Access to the internet.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Active Control Condition
|
The active control condition includes an online self-awareness program that lasts approximately 40-50 minutes.
Participants in the control condition will receive access to the intervention after data collection for the study has been completed.
|
|
Experimental: Common Elements Toolbox (COMET)
|
COMET is an online unguided self-help intervention that lasts approximately 40-50 minutes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Patient Health Questionnaire-8 (PHQ-8)
Time Frame: Up to 4 weeks post-intervention
|
Depression questionnaire.
Scores range from 0 to 24.
Lower scores indicate less depression.
|
Up to 4 weeks post-intervention
|
|
Change in Generalized Anxiety Disorder Screener-7 (GAD-7)
Time Frame: Up to 4 weeks post-intervention
|
Anxiety questionnaire.
Total scores range from 0-21.
Lower scores indicate less anxiety.
|
Up to 4 weeks post-intervention
|
|
Change in the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS)
Time Frame: Up to 4 weeks post-intervention
|
Subjective Well-being questionnaire.
Total scores range from 7 to 35.
Higher values indicate higher well-being scores.
|
Up to 4 weeks post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ratings on the Acceptability of Intervention Measure (AIM)
Time Frame: Immediately after the intervention
|
Questionnaire measuring the acceptability of an intervention.
Acceptability refers to the perception that a given treatment is agreeable or satisfactory.
The total score ranges from 4 to 20.
Higher scores indicate higher acceptability ratings.
|
Immediately after the intervention
|
|
Ratings on the Intervention Appropriateness Measure (IAM)
Time Frame: Immediately after the intervention
|
Questionnaire measuring the appropriateness of an intervention.
Appropriateness refers to the perceived fit or relevance of an intervention.
The total score ranges from 4 to 20.
Higher scores indicate higher appropriateness.
|
Immediately after the intervention
|
|
Secondary Control
Time Frame: Up to 4 weeks post-intervention
|
The investigators will ask participants three items to assess secondary control (Weisz et al., 2010).
The items are scored on a 4-point Likert scale, ranging from 0 ("Very false") to 3 ("Very true").
The three items are: When something bad happens, I can find a way to think about it that makes me feel better.
After a really hard day, I can make myself feel better by remembering some good things that happened.
When bad things happen to me that I can't control, there are lots of things I can do to feel better.
Higher scores indicate greater secondary control.
|
Up to 4 weeks post-intervention
|
|
Perceived Utility
Time Frame: Immediately after intervention
|
Participants will be asked to rate three items relating to the perceived utility of each module.
Specifically, the investigators asked participants: How helpful the module was; How engaging the module was; How much they will continue applying content from the module.
If items are at least moderately correlated (r > .5) the investigators will combine them in a single measure of perceived utility.
Higher scores indicate greater perceived utility.
|
Immediately after intervention
|
|
Positive and Negative Affect Schedule (PANAS)
Time Frame: Up to 4 weeks post-intervention
|
Questionnaire measuring positive affect and negative affect.
Scores on the positive affect subscale range from 10-50, with higher scores representing higher levels of positive affect.
Scores on the negative affect subscale range from 10-50, with lower scores representing lower levels of negative affect.
|
Up to 4 weeks post-intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 844481
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.